DZ2044A1 - 5,6-Dihydro-9h-pyrazolo Ä3,4-cÜ-1,2,4-triazol Ä4,3-alphaÜpyridines tricycliques procédé pour leur préparation et compositions les contenant. - Google Patents

5,6-Dihydro-9h-pyrazolo Ä3,4-cÜ-1,2,4-triazol Ä4,3-alphaÜpyridines tricycliques procédé pour leur préparation et compositions les contenant.

Info

Publication number
DZ2044A1
DZ2044A1 DZ960088A DZ960088A DZ2044A1 DZ 2044 A1 DZ2044 A1 DZ 2044A1 DZ 960088 A DZ960088 A DZ 960088A DZ 960088 A DZ960088 A DZ 960088A DZ 2044 A1 DZ2044 A1 DZ 2044A1
Authority
DZ
Algeria
Prior art keywords
tricycliques
alphaüpyridines
pyrazolo
triazol
dihydro
Prior art date
Application number
DZ960088A
Other languages
English (en)
Inventor
Allen Jacob Duplantier
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2044A1 publication Critical patent/DZ2044A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ960088A 1995-06-06 1996-06-05 5,6-Dihydro-9h-pyrazolo Ä3,4-cÜ-1,2,4-triazol Ä4,3-alphaÜpyridines tricycliques procédé pour leur préparation et compositions les contenant. DZ2044A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002223624A CA2223624C (fr) 1995-06-06 1995-06-06 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2-4-triazolo[4,3-.alpha.]pyridines tricycliques
PCT/IB1995/000429 WO1996039408A1 (fr) 1995-06-06 1995-06-06 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2-4-TRIAZOLO[4,3-α]PYRIDINES TRICYCLIQUES
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DZ2044A1 true DZ2044A1 (fr) 2002-07-21

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ960088A DZ2044A1 (fr) 1995-06-06 1996-06-05 5,6-Dihydro-9h-pyrazolo Ä3,4-cÜ-1,2,4-triazol Ä4,3-alphaÜpyridines tricycliques procédé pour leur préparation et compositions les contenant.

Country Status (43)

Country Link
US (1) US6004974A (fr)
EP (1) EP0837860B1 (fr)
JP (1) JP3107827B2 (fr)
KR (2) KR100191972B1 (fr)
CN (1) CN1061044C (fr)
AP (1) AP609A (fr)
AR (1) AR002745A1 (fr)
AT (1) ATE214700T1 (fr)
AU (1) AU694871B2 (fr)
BG (1) BG62568B1 (fr)
BR (1) BR9602627A (fr)
CA (1) CA2223624C (fr)
CO (1) CO4700460A1 (fr)
CZ (1) CZ287251B6 (fr)
DE (1) DE69525978T2 (fr)
DK (1) DK0837860T3 (fr)
DZ (1) DZ2044A1 (fr)
ES (1) ES2172583T3 (fr)
FI (1) FI114097B (fr)
HR (1) HRP960268B1 (fr)
HU (1) HUP9601541A3 (fr)
IL (1) IL118485A (fr)
IS (1) IS1913B (fr)
LV (1) LV11620B (fr)
MA (1) MA23893A1 (fr)
MX (1) MX9709897A (fr)
MY (1) MY116527A (fr)
NO (1) NO306256B1 (fr)
NZ (1) NZ286734A (fr)
OA (1) OA10458A (fr)
PL (1) PL184195B1 (fr)
PT (1) PT837860E (fr)
RO (1) RO115881B1 (fr)
RU (1) RU2161158C2 (fr)
SA (1) SA96170065B1 (fr)
SG (1) SG54341A1 (fr)
SI (1) SI9600186A (fr)
SK (1) SK282167B6 (fr)
TN (1) TNSN96083A1 (fr)
TR (1) TR199600482A1 (fr)
TW (1) TW460469B (fr)
WO (1) WO1996039408A1 (fr)
YU (1) YU49346B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1380585B1 (fr) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinone comme intermédiaire
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
CA2402384A1 (fr) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Inhibiteurs benzyles de pde4
AU2002314102A1 (en) * 2001-05-25 2002-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
BR0209992A (pt) * 2001-05-25 2004-04-06 Pfizer Inibidor de pde4 e um agente anticolinérgico em combinação para o tratamento de doenças obstrutivas das vias respiratórias
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
WO2006075748A1 (fr) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. Agent therapeutique pour maladie conjonctivale allergique
JP2009512676A (ja) 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体アンタゴニストの医薬組成物
CN102772411A (zh) 2006-07-05 2012-11-14 奈科明有限责任公司 用于治疗炎症性肺部疾病的HMG-CoA还原酶抑制剂与磷酸二酯酶4抑制剂的组合
JP5579724B2 (ja) * 2008-10-17 2014-08-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ホスファチジルイノシトール−３−キナーゼ（ｐｉ−３キナーゼ）阻害剤としてのテトラ−アザ−複素環
JP5730896B2 (ja) * 2009-12-04 2015-06-10 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ トリシクロピラゾール誘導体
WO2013084182A1 (fr) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Composition pharmaceutique comprenant un inhibiteur de l'enzyme pde4 et un agent analgésique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
CA2166721C (fr) * 1993-07-06 1999-07-27 Allen Jacob Duplantier Tetrahydropyrazolopyridines bicycliques
CA2143143A1 (fr) * 1994-03-08 1995-09-09 Toshihiko Tanaka Derives de la 3-phenylpyrrolidine

Also Published As

Publication number Publication date
CZ162696A3 (en) 1997-01-15
KR100191972B1 (ko) 1999-06-15
MX9709897A (es) 1998-03-31
HRP960268B1 (en) 2002-12-31
TW460469B (en) 2001-10-21
PL184195B1 (pl) 2002-09-30
CN1061044C (zh) 2001-01-24
JP3107827B2 (ja) 2000-11-13
WO1996039408A1 (fr) 1996-12-12
DE69525978D1 (de) 2002-04-25
BG100640A (bg) 1997-03-31
CZ287251B6 (en) 2000-10-11
AR002745A1 (es) 1998-04-29
US6004974A (en) 1999-12-21
JPH10510242A (ja) 1998-10-06
HRP960268A2 (en) 1997-08-31
FI114097B (fi) 2004-08-13
SK71896A3 (en) 1997-05-07
YU34696A (sh) 1999-07-28
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
HUP9601541A3 (en) 1997-05-28
NO962320L (no) 1996-12-09
TR199600482A1 (tr) 1997-03-21
AP9600806A0 (en) 1996-07-31
EP0837860B1 (fr) 2002-03-20
LV11620A (lv) 1996-12-20
SG54341A1 (en) 1998-11-16
CA2223624A1 (fr) 1996-12-12
IS1913B (is) 2004-02-03
IL118485A0 (en) 1996-09-12
BG62568B1 (bg) 2000-02-29
IS4350A (is) 1996-12-07
CO4700460A1 (es) 1998-12-29
YU49346B (sh) 2005-07-19
MY116527A (en) 2004-02-28
RU2161158C2 (ru) 2000-12-27
CA2223624C (fr) 2001-02-20
MA23893A1 (fr) 1996-12-31
OA10458A (en) 2002-03-27
NZ286734A (en) 1998-02-26
DK0837860T3 (da) 2002-05-27
NO306256B1 (no) 1999-10-11
IL118485A (en) 2000-02-17
ATE214700T1 (de) 2002-04-15
PL314459A1 (en) 1996-12-09
SK282167B6 (sk) 2001-11-06
EP0837860A1 (fr) 1998-04-29
FI974434A0 (fi) 1997-12-05
HUP9601541A2 (en) 1997-02-28
BR9602627A (pt) 1998-09-01
AU694871B2 (en) 1998-07-30
DE69525978T2 (de) 2002-12-19
AP609A (en) 1997-09-03
HU9601541D0 (en) 1996-07-29
TNSN96083A1 (fr) 2005-03-15
CN1142499A (zh) 1997-02-12
RO115881B1 (ro) 2000-07-28
KR970003440A (ko) 1997-01-28
AU5477396A (en) 1996-12-19
NO962320D0 (no) 1996-06-05
LV11620B (en) 1997-04-20
KR100225719B1 (en) 1999-10-15
ES2172583T3 (es) 2002-10-01
SI9600186A (en) 1997-04-30
FI974434A (fi) 1997-12-05

Similar Documents

Publication Publication Date Title
DZ2045A1 (fr) Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
DZ2217A1 (fr) Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
DZ2889A1 (fr) 4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2172A1 (fr) Dérivés de triazole utiles on thérapeutique, procédé pour leur préparation et compositions les contenant.
DZ2962A1 (fr) Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2128A1 (fr) Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr) 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2753A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
DZ2300A1 (fr) Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr) Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2037A1 (fr) Amines bicyclique utiles comme insecticides, procédé pour leur préparation et compositions les contenant.
DZ2465A1 (fr) Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions les contenant.
MA23866A1 (fr) N-(indole-2-carbonyl)-glycinamides substitues, procede pour leur preparation et compositions les contenant
DZ2745A1 (fr) BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2729951B1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2358A1 (fr) Amides inhibiteurs de sécrétion de apo b/mtp procédé pour leur préparation et compositions pharmaceutiques les contenant
MA26439A1 (fr) Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
CY2537B1 (fr) Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA22521A1 (fr) Compositions anti- transpirantes en batonnets-gels contenant un derive de la 2-oxazolidinone, et procede pour leur preparation
DZ1957A1 (fr) Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2044A1 (fr) 5,6-Dihydro-9h-pyrazolo Ä3,4-cÜ-1,2,4-triazol Ä4,3-alphaÜpyridines tricycliques procédé pour leur préparation et compositions les contenant.
MA26519A1 (fr) Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.